Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / *W EXP 09/02/202
-
Total 13F shares
-
2,110,267
-
Share change
-
+2,110,267
-
Total reported value
-
$332,083
-
Price per share
-
$0.16
-
Number of holders
-
11
-
Value change
-
+$332,083
-
Number of buys
-
11
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) as of Q1 2023
As of 31 Mar 2023,
ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,110,267 shares.
The largest 10 holders included
Sio Capital Management, LLC, Fort Baker Capital Management LP, Ikarian Capital, LLC, CITADEL ADVISORS LLC, CLEAR STREET LLC, JPMORGAN CHASE & CO, Affinity Asset Advisors, LLC, HRT FINANCIAL LP, Privium Fund Management B.V., and Ancora Advisors, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.